Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways

Doxorubicin (DOX) selection of CCRF-CEM leukaemia cell line resulted in multidrug resistance (MDR) CEM/A7R cell line, which overexpresses MDR, 1 coded P-glycoprotein (Pgp). Here, we report for the first time that oncoprotein Cripto, a founding member of epidermal growth factor-Cripto-FRL, 1-Criptic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, X F, Li, J, Yang, E, Vandervalk, S, Xing, P X
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360102/
https://www.ncbi.nlm.nih.gov/pubmed/17342096
http://dx.doi.org/10.1038/sj.bjc.6603641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360102/
https://www.ncbi.nlm.nih.gov/pubmed/17342096
http://dx.doi.org/10.1038/sj.bjc.6603641

Ejemplares similares